ConductScience.org, home

Library / Trials

Effectiveness of Two Diaphragmatic Strengthening Programs on Symptoms of LPR as Measured by the Reflux Symptom Index (RSI) and the Reflux Disease Questionnaire (RDQ)

NCT07931105, Not applicable, Completed, Mayo Clinic

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleEffectiveness of Two Diaphragmatic Strengthening Programs on Symptoms of LPR as Measured by the Reflux Symptom Index (RSI) and the Reflux Disease Questionnaire (RDQ)ClinicalTrials.gov
NCT numberNCT07931105ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment69 participants, actualClinicalTrials.gov
Lead sponsorMayo ClinicClinicalTrials.gov
ConditionsLaryngeal/Pharyngeal Reflux (LPR)ClinicalTrials.gov
InterventionsStandard abdominal breathing, Resisted ExerciseClinicalTrials.gov
First posted2026-11-12ClinicalTrials.gov
Last updated2026-11-12ClinicalTrials.gov

Registered outcomes 2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in Reflux Symptom Index (RSI) ScoreBaseline, 1 month, 3 months, 6 months
The RSI is a 9-item questionnaire evaluating the severity of nine common LPR-related throat and voice symptoms over the past month. Each symptom is rated from 0 (no problem) to 5 (severe problem), with total scores ranging from 0-45. Higher scores indicate greater laryngopharyngeal reflux symptom severity.
ClinicalTrials.gov
PrimaryChange in Reflux Disease Questionnaire (RDQ) ScoreBaseline, 1 month, 3 months, 6 months
The RDQ is used to quantify gastroesophageal reflux disease (GERD) symptoms in adults. The RDQ has six symptom items (heartburn, regurgitation, dyspepsia). Each item is rated on two separate 0-5 scales: Frequency (0 = never, 5 = daily) and Severity (0 = did not have, 5 = severe). Each item's frequency + severity sum is averaged across the two items in that symptom dimension, and the overall RDQ score is the mean of all 12 ratings (6 items × 2 facets). Higher scores indicate greater reflux symptom severity.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 4

FieldValueSource
Releasetrials-2026-11-12-0.3.0ClinicalTrials.gov
Release manifest SHA-2564a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.3.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.